Neuroradiology: Page 179

MRI shows brain tissue loss with antipsychotic drugs
By Wayne Forrest
With the help of MRI, researchers have found that antipsychotic drugs contribute to a subtle but measurable amount of brain tissue loss over time in patients with schizophrenia, according to study published in the February issue of the Archives of General Psychiatry.
February 8, 2011
Positron may expand Attrius market
By AuntMinnie.com staff writers
Molecular imaging developer Positron said it plans to explore additional market opportunities for its Attrius PET scanner.
February 7, 2011
FDA panel gives nod to Bayer's Gadovist MRI contrast agent
By Wayne Forrest
An advisory committee of the U.S. Food and Drug Administration today voted unanimously to recommend approval for Bayer HealthCare Pharmaceuticals' Gadovist 1.0 (gadobutrol), a gadolinium-based contrast agent for contrast-enhanced MRI of the central nervous system.
January 20, 2011
FDA panel gives Amyvid PET agent conditional approval
By Wayne Forrest
With a unanimous 16-0 decision, an advisory committee of the U.S. Food and Drug Administration voted on January 20 to conditionally recommend approval of Eli Lilly's PET imaging agent Amyvid (florbetapir) for detecting beta amyloid plaque deposits that could be precursors to Alzheimer's disease.
January 19, 2011
PET with florbetapir may help detect Alzheimer's signs
By Wayne Forrest
PET imaging with the biomarker florbetapir is showing promise in preliminary research to detect the presence of beta amyloid in the brains of living patients to potentially confirm Alzheimer's disease, according to a study in the January 19 issue of the Journal of the American Medical Association.
January 17, 2011
GE gets FDA nod for DaTscan
By AuntMinnie.com staff writers
GE Healthcare has received U.S. Food and Drug Administration clearance for its DaTscan (ioflupane I-123 injection) radiopharmaceutical agent.
January 13, 2011
GE touts flutemetamol studies for AD
By AuntMinnie.com staff writers
New clinical research data suggest that GE Healthcare's F-18 flutemetamol radiopharmaceutical could provide accurate identification of beta amyloid plaques, which have been linked to Alzheimer's disease (AD).
January 13, 2011
Advance in MRI allows faster brain scans
By AuntMinnie.com staff writers
Researchers from several institutions believe they have achieved a breakthrough in MRI that would enable brain scans to be performed more than seven times faster than currently possible.
January 5, 2011
2011 01 06 10 50 21 603 Mri Brain Scan 250
Functional MRI helps detect effects of nicotine on brain
By Wayne Forrest
With the help of functional MRI, researchers have discovered which regions of nicotine-dependent smokers' brains are activated by cigarette-related cues, according to two reports posted online December 30 in the Archives of General Psychiatry.
January 3, 2011
PET may help find cause for epileptic brain disease in kids
By Wayne Forrest
With the help of FDG-PET, French researchers have discovered a common brain dysfunction among school-age children afflicted with fever-induced refractory epileptic encephalopathy, according to a study published in the January edition of the Journal of Nuclear Medicine.
January 2, 2011
2011 01 03 13 11 08 640 Epilepsy Mazzuca 01 Thumb
Neuroimaging predicts pediatric seizures in child abuse
By Cynthia E. Keen
Neuroimaging is an important tool to identify and evaluate traumatic head injury in victims of child abuse. Now, specific findings on CT and MRI can predict which patients have the highest risk for seizures, according to a study published online in Neurocritical Care.
December 28, 2010
Lilly wraps up Avid buy, lands FDA priority review
By AuntMinnie.com staff writers
Pharmaceutical giant Eli Lilly has finalized its acquisition of molecular imaging developer Avid Radiopharmaceuticals of Philadelphia.
December 22, 2010
Previous Page
Page 179 of 239
Next Page